Trimi vs Shed
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
Says outright that its headline is a monthly equivalent of annual billing, and prints the no-commitment rate beside it instead of leaving you to find it at checkout.
from $99/mo on a 12-month prepaid plan
Verified 2026-09-21
PickFour delivery formats (weekly injections, daily oral drops, sublingual and pills) plus brand-name Wegovy/Zepbound, from a Utah-based provider with a real, disclosed company address.
from $159/mo on a 12-month plan ($199 month to month)
Verified 2026-09-14
Visit →Affiliate link
| Trimi | Shed | |
|---|---|---|
| Price | from $99/mo on a 12-month prepaid planTheir page, read 2026-09-21 | from $159/mo on a 12-month plan ($199 month to month)Their page, read 2026-09-14 |
| Price shape | one-ongoing-rate | one-ongoing-rate |
| What the price doesn’t say | $99/mo is a monthly equivalent of $1,188 billed upfront on a 12-month commitment. Not a month you can pay and stop. With no commitment it is $175/mo. Tirzepatide is $125/mo on the same 12-month basis, or $235/mo with no commitment. | $159/mo is the semaglutide rate; tirzepatide is $239/mo. The $149/mo quoted for Foundayo (oral orforglipron) is the misleading one. It excludes a $125/mo Shed membership and provider fee paid directly to Shed, so that route is $274/mo all in, the most expensive option here rather than the cheapest. |
| What it covers | 12 months of compounded semaglutide, supplies, licensed provider care, ongoing support and free overnight shippingTheir page, read 2026-09-21 | Not published. The page does not say what the figure covers.Their page, read 2026-09-14 |
| Billed on top | Not recorded. We have not found a statement either way.Their page, read 2026-09-21 | Not recorded. We have not found a statement either way.Their page, read 2026-09-14 |
| Commitment | Committed term. The rate applies on a 12-month prepaid plan. Billed up front on that term. What happens after the first period: Trimi states on the page that the figures shown are monthly equivalents of annual billing, and prints the no-commitment rate ($175/mo semaglutide, $235/mo tirzepatide) next to them.Their page, read 2026-09-21 | Committed term. The rate applies on a 12-month plan ($199 month to month).Their page, read 2026-09-14 |
| Routes | compounded semaglutide, compounded tirzepatide | compounded semaglutide, compounded tirzepatide, oral drops, sublingual, brand-name Foundayo orforglipron tablet, brand-name Wegovy, brand-name Zepbound |
| Score | 7.9 | 7.3 |
What one does that the other doesn’t
Trimi
Nothing Shed does not also offer, on the routes we record.
Shed
Offers oral/sublingual, brand-name where Trimi does not.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
Trimi
- Lower published entry figure of the two.Basis: published entry price, each in its own billing unit
- Scores clearly higher on transparency (9.0 vs 7.5).Basis: our published scoring rubric
- Scores clearly higher on pricing (8.5 vs 6.5).Basis: our published scoring rubric
Shed
- Only one of the two offering: oral/sublingual, brand-name.Basis: published treatments, by drug and route
- Scores clearly higher on treatment (8.5 vs 6.5).Basis: our published scoring rubric